Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-12Clinical Trial Update: Pharmacogenomic and Circulating Biomarkers for CDK4/6 Inhibitors
A ClinicalTrials.gov update describing a trial focused on pharmacogenomics and circulating biomarkers for CDK4/6 inhibitors in breast cancer…
-
CLINICAL_TRIALS trial_result · 2025-12-12Clinical Trial Update: TARGeted Intraoperative radioTherapy With INTRABEAM as a Boost for Breast Cancer - A Quality Control Registry
A quality-control registry evaluated targeted intraoperative radiotherapy using the INTRABEAM device as a boost for breast cancer; the study…
-
CLINICAL_TRIALS research · 2025-12-12Clinical Trial Update: Preoperative Irradiation for Stage I Breast Cancer [NA]
A clinical trial sponsored by Parul Barry is evaluating preoperative irradiation for stage I breast cancer. The study is currently recruitin…
-
CLINICAL_TRIALS research · 2025-12-12Clinical Trial Update: The Engaging Primary Care in Cancer Survivorship (EPICS) Study [NA]
The EPICS study (Engaging Primary Care in Cancer Survivorship) sponsored by Kaiser Permanente examines primary-care involvement in cancer su…
-
CLINICAL_TRIALS trial_result · 2025-12-12Clinical Trial Update: Clinical Trial of Evaluating TQB3912 Tablets Combined With Fulvestrant Injection±TQB3616 Capsules for Locally Advanced or Metastatic Hormone Receptor(HR)-Positive and Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer [Phase 1, Phase 2]
A clinical trial update indicates the Phase 1/2 study evaluating TQB3912 tablets with fulvestrant, with or without TQB3616, for locally adva…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-11Clinical Trial Update: A Novel Therapy for Breast Cancer Survivors With Genitourinary Syndrome of Menopause [Phase 2]
Phase 2 clinical trial update on a novel therapy for breast cancer survivors with genitourinary syndrome of menopause.
-
CLINICAL_TRIALS research · 2025-12-11Clinical Trial Update: Dalpiciclib Plus AI (Neoadjuvant Endocrine Therapy) Compared With Neoadjuvant Chemotherapy in Early Breast Cancer （EBC） [Phase 2]
Phase 2 trial evaluating dalpiciclib in combination with an aromatase inhibitor as neoadjuvant therapy for early breast cancer. The trial co…
-
CLINICAL_TRIALS trial_result · 2025-12-11Clinical Trial Update: HOPE-Genomics Intervention for the Improvement of Cancer Patient Knowledge of Genomics [NA]
A clinical trial update for the HOPE-Genomics intervention aimed at improving cancer patients' knowledge of genomics, with results posted on…
-
CLINICAL_TRIALS research · 2025-12-11Clinical Trial Update: Intravital Microscopy in Human Solid Tumors [NA]
Mayo Clinic is conducting a clinical trial using intravital microscopy in multiple solid tumors, currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-11Clinical Trial Update: Hippocampal Avoidance in Craniospinal Irradiation for the Treatment of Leptomeningeal Metastases From Breast Cancer or Non-small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial evaluating hippocampal avoidance in craniospinal irradiation for leptomeningeal metastases from breast cancer or no…
-
CLINICAL_TRIALS research · 2025-12-11Clinical Trial Update: A Study of MT-4561 in Patients With Various Advanced Solid Tumors [Phase 1, Phase 2]
This trial update reports that MT-4561 is being studied in multiple advanced solid tumors across Phase 1/Phase 2 and is currently recruiting…
-
CLINICAL_TRIALS trial_result · 2025-12-11Clinical Trial Update: Project 1: Self-Triage by 2D Full-field Digital Mammography or Synthetic Images [NA]
A completed clinical trial from Brigham and Women's Hospital evaluated self-triage using 2D full-field digital mammography or synthetic imag…
-
CLINICAL_TRIALS research · 2025-12-11Clinical Trial Update: Genetic Counseling Patient Preference Intervention Versus Conventional Genetic Counseling for Women at Elevated Risk for Breast Cancer [NA]
Clinical trial update comparing a genetic counseling patient-preference intervention to conventional genetic counseling for women at elevate…
-
CLINICAL_TRIALS research · 2025-12-11Clinical Trial Update: A Study of SKB264 Versus Investigator's Choice of Chemotherapy in Subjects With Unresectable Locally Advanced, Relapsed, or Metastatic HR+/HER2- Breast Cancer Who Have Previously Failed Endocrine Therapy [Phase 3]
Phase 3 randomized trial comparing SKB264 against investigator's choice chemotherapy in patients with unresectable locally advanced, relapse…
-
CLINICAL_TRIALS research · 2025-12-11Clinical Trial Update: A Study of GC101 TIL in Advanced Breast Cancer (10hospital) [EARLY_Phase 1]
An early-phase study evaluating GC101 TIL therapy for advanced breast cancer, currently recruiting at 10 hospitals.
-
CLINICAL_TRIALS research · 2025-12-11Clinical Trial Update: Chemotherapy Combined With Bevacizumab Neoadjuvant Therapy for HER2-negative Breast Cancer [Phase 4]
A Phase 4 study is evaluating chemotherapy plus bevacizumab as neoadjuvant therapy for HER2-negative breast cancer. The trial is currently r…
-
CLINICAL_TRIALS research · 2025-12-11Clinical Trial Update: A Study of GC203 TIL in Advanced Malignant Solid Tumors [Phase 1]
This Phase 1 study of GC203 TIL in advanced malignant solid tumors is currently recruiting across multiple cancer types, including gynecolog…
-
CLINICAL_TRIALS research · 2025-12-11Clinical Trial Update: Remotely Delivered, Community-Aligned Weight Loss Interventions Among Breast Cancer Survivors, ¡Vida! Trial [NA]
A trial evaluating remotely delivered weight loss interventions for breast cancer survivors, with recruitment ongoing under the ¡Vida! study…
-
CLINICAL_TRIALS research · 2025-12-11Clinical Trial Update: Adaptive Chemotherapy for the Treatment of Advanced Breast Cancer [Phase 3]
A Phase 3 clinical trial evaluating adaptive chemotherapy for advanced breast cancer is currently recruiting. The sponsor is Sun Yat-sen Uni…
-
CLINICAL_TRIALS trial_result · 2025-12-10Clinical Trial Update: Palbociclib With Fulvestrant for Metastatic Breast Cancer After Treatment With Palbociclib and an Aromatase Inhibitor [Phase 2]
Phase 2 trial update assessing the combination of palbociclib with fulvestrant in metastatic breast cancer patients who previously received …
-
CLINICAL_TRIALS research · 2025-12-10Clinical Trial Update: Survival Endpoints in Women Treated for Metastatic Breast Cancer: Contribution of Real-life Databases
This ClinicalTrials.gov entry reports on a study examining survival endpoints in women with metastatic breast cancer and how real-world data…
-
CLINICAL_TRIALS trial_result · 2025-12-10Clinical Trial Update: Efficacy and Safety of the Combination of Trastuzumab Plus TUCAtinib Plus viNorelbine in Patients With HER2-positive Non-resectable Locally Advanced or Metastatic Breast Cancer [Phase 2]
A Phase 2 trial evaluating the combination of trastuzumab, tucatinib, and vinorelbine in HER2-positive locally advanced or metastatic breast…
-
CLINICAL_TRIALS trial_result · 2025-12-10Clinical Trial Update: Evaluation of Efficiency in Cancerology of New Technologies as Telemedicine and Conected Objects (e-DomSanté)
A trial evaluating the use of telemedicine and connected devices in breast cancer care (e-DomSanté); the study has completed and results hav…
-
CLINICAL_TRIALS trial_result · 2025-12-10Clinical Trial Update: Evaluation of a Once Per Day Regimen of Accelerated Partial Breast Irradiation for Improved Breast Appearance in Pts w/Low Risk, Hormone Responsive Brst Ca [Phase 2]
Phase 2 trial evaluating a once-daily accelerated partial breast irradiation regimen for low-risk, hormone receptor-positive breast cancer; …
-
CLINICAL_TRIALS research · 2025-12-10Clinical Trial Update: A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer [Phase 2]
Phase 2 study evaluating alisertib in combination with endocrine therapy for hormone receptor-positive, HER2-negative breast cancer that is …